224 related articles for article (PubMed ID: 9798075)
1. Effects of clozapine on auditory event-related potentials in schizophrenia.
Umbricht D; Javitt D; Novak G; Bates J; Pollack S; Lieberman J; Kane J
Biol Psychiatry; 1998 Oct; 44(8):716-25. PubMed ID: 9798075
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiological indices of automatic and controlled auditory information processing in first-episode, recent-onset and chronic schizophrenia.
Umbricht DS; Bates JA; Lieberman JA; Kane JM; Javitt DC
Biol Psychiatry; 2006 Apr; 59(8):762-72. PubMed ID: 16497277
[TBL] [Abstract][Full Text] [Related]
3. Effects of olanzapine on auditory P300 and mismatch negativity (MMN) in schizophrenia spectrum disorders.
Korostenskaja M; Dapsys K; Siurkute A; Maciulis V; Ruksenas O; Kähkönen S
Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):543-8. PubMed ID: 15866356
[TBL] [Abstract][Full Text] [Related]
4. Impaired mismatch negativity generation reflects widespread dysfunction of working memory in schizophrenia.
Javitt DC; Doneshka P; Grochowski S; Ritter W
Arch Gen Psychiatry; 1995 Jul; 52(7):550-8. PubMed ID: 7598631
[TBL] [Abstract][Full Text] [Related]
5. Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients.
Krakowski MI; Czobor P; Nolan KA
J Clin Psychopharmacol; 2008 Oct; 28(5):485-93. PubMed ID: 18794642
[TBL] [Abstract][Full Text] [Related]
6. P300 alterations in schizophrenic patients experiencing auditory hallucinations.
Papageorgiou C; Oulis P; Vasios C; Kontopantelis E; Uzunoglu N; Rabavilas A; Christodoulou GN
Eur Neuropsychopharmacol; 2004 May; 14(3):227-36. PubMed ID: 15056482
[TBL] [Abstract][Full Text] [Related]
7. Clozapine action on auditory P3 response in schizophrenia.
Niznikiewicz MA; Patel JK; McCarley R; Sutton J; Chau DT; Wojcik J; Green AI
Schizophr Res; 2005 Jul; 76(1):119-21. PubMed ID: 15927806
[No Abstract] [Full Text] [Related]
8. What do ERPs and ERFs reveal about the effect of antipsychotic treatment on cognition in schizophrenia?
Korostenskaja M; Kähkönen S
Curr Pharm Des; 2009; 15(22):2573-93. PubMed ID: 19689329
[TBL] [Abstract][Full Text] [Related]
9. Effects of clozapine on awareness of illness and cognition in schizophrenia.
Pallanti S; Quercioli L; Pazzagli A
Psychiatry Res; 1999 Jun; 86(3):239-49. PubMed ID: 10482343
[TBL] [Abstract][Full Text] [Related]
10. MMN responsivity to manipulations of frequency and duration deviants in chronic, clozapine-treated schizophrenia patients.
Horton J; Millar A; Labelle A; Knott VJ
Schizophr Res; 2011 Mar; 126(1-3):202-11. PubMed ID: 21194893
[TBL] [Abstract][Full Text] [Related]
11. N2 and P3 components of event-related potential in first-episode schizophrenic patients: scalp topography, medication, and latency effects.
Demiralp T; Uçok A; Devrim M; Isoglu-Alkaç U; Tecer A; Polich J
Psychiatry Res; 2002 Aug; 111(2-3):167-79. PubMed ID: 12374634
[TBL] [Abstract][Full Text] [Related]
12. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications.
Light GA; Geyer MA; Clementz BA; Cadenhead KS; Braff DL
Am J Psychiatry; 2000 May; 157(5):767-71. PubMed ID: 10784470
[TBL] [Abstract][Full Text] [Related]
13. ERPs in schizophrenia: effects of antipsychotic medication.
Ford JM; White PM; Csernansky JG; Faustman WO; Roth WT; Pfefferbaum A
Biol Psychiatry; 1994 Aug; 36(3):153-70. PubMed ID: 7948453
[TBL] [Abstract][Full Text] [Related]
14. Effects of risperidone on auditory event-related potentials in schizophrenia.
Umbricht D; Javitt D; Novak G; Bates J; Pollack S; Lieberman J; Kane J
Int J Neuropsychopharmacol; 1999 Dec; 2(4):299-304. PubMed ID: 11285146
[TBL] [Abstract][Full Text] [Related]
15. Lamotrigine augmentation in patients with schizophrenia who show partial response to clozapine treatment.
Vayısoğlu S; Anıl Yağcıoğlu AE; Yağcıoğlu S; Karahan S; Karcı O; Gürel SC; Yazıcı MK
Schizophr Res; 2013 Jan; 143(1):207-14. PubMed ID: 23217729
[TBL] [Abstract][Full Text] [Related]
16. Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication.
Stefánsson SB; Jónsdóttir TJ
Biol Psychiatry; 1996 Jul; 40(1):19-27. PubMed ID: 8780851
[TBL] [Abstract][Full Text] [Related]
17. P300 and symptom improvement in schizophrenia.
Gallinat J; Riedel M; Juckel G; Sokullu S; Frodl T; Moukhtieva R; Mavrogiorgou P; Nisslé S; Müller N; Danker-Hopfe H; Hegerl U
Psychopharmacology (Berl); 2001 Oct; 158(1):55-65. PubMed ID: 11685384
[TBL] [Abstract][Full Text] [Related]
18. Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients.
Adler LE; Olincy A; Cawthra EM; McRae KA; Harris JG; Nagamoto HT; Waldo MC; Hall MH; Bowles A; Woodward L; Ross RG; Freedman R
Am J Psychiatry; 2004 Oct; 161(10):1822-8. PubMed ID: 15465979
[TBL] [Abstract][Full Text] [Related]
19. Glutamatergic modulation of auditory information processing in the human brain.
Gunduz-Bruce H; Reinhart RM; Roach BJ; Gueorguieva R; Oliver S; D'Souza DC; Ford JM; Krystal JH; Mathalon DH
Biol Psychiatry; 2012 Jun; 71(11):969-77. PubMed ID: 22036036
[TBL] [Abstract][Full Text] [Related]
20. Do atypical antipsychotics fail to exert cognitive sparing effects?
Papageorgiou C; Oulis P; Vasios C; Matsopoulos GK; Uzunoglu N; Rabavilas A; Christodoulou GN
Neuroreport; 2003 Mar; 14(3):505-9. PubMed ID: 12634513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
